Literature DB >> 227508

Naloxone reverses the antihypertensive effect of clonidine.

C Farsang, G Kunos.   

Abstract

In unanesthetized, spontaneously hypertensive rats the decrease in blood pressure and heart rate produced by intravenous clonidine, 5 to 20 micrograms/kg, was inhibited or reversed by nalozone, 0.2 to 2 mg/kg. The hypotensive effect of 100 mg/kg alpha-methyldopa was also partially reversed by naloxone. Naloxone alone did not affect either blood pressure or heart rate. In brain membranes from spontaneously hypertensive rats clonidine, 10(-8) to 10(-5) M, did not influence stereoselective binding of [3H]-naloxone (8 nM), and naloxone, 10(-8) to 10(-4) M, did not influence clonidine-suppressible binding of [3H]-dihydroergocryptine (1 nM). These findings indicate that in spontaneously hypertensive rats the effects of central alpha-adrenoceptor stimulation involve activation of opiate receptors. As naloxone and clonidine do not appear to interact with the same receptor site, the observed functional antagonism suggests the release of an endogenous opiate by clonidine or alpha-methyldopa and the possible role of the opiate in the central control of sympathetic tone.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227508      PMCID: PMC2043886          DOI: 10.1111/j.1476-5381.1979.tb08661.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine.

Authors:  G K Aghajanian
Journal:  Nature       Date:  1978-11-09       Impact factor: 49.962

2.  Dihydroergocryptine binding and alpha-adrenoreceptors in smooth muscle.

Authors:  G Kunos; B Hoffman; Y N Kwok; W H Kan; L Mucci
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

3.  Opiate antagonist reverses the cardiovascular effects of inhalation anaesthesia.

Authors:  J O Arndt; E Freye
Journal:  Nature       Date:  1979-02-01       Impact factor: 49.962

4.  alpha-Noradrenergic receptors in the brain: differential effects of sodium on binding of [3H]agonists and [3H]antagonists.

Authors:  D A Greenberg; D C U'Prichard; P Sheehan; S H Snyder
Journal:  Brain Res       Date:  1978-01-27       Impact factor: 3.252

5.  Clonidine-induced hypotension: further evidence for a central interaction with histamine H2 receptor antagonists in the rat.

Authors:  L Finch; C A Harvey; P E Hicks; D A Owen
Journal:  Neuropharmacology       Date:  1978 Apr-May       Impact factor: 5.250

6.  Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock.

Authors:  J W Holaday; A I Faden
Journal:  Nature       Date:  1978-10-05       Impact factor: 49.962

7.  Clonidine withdrawal. Mechanism and frequency of rebound hypertension.

Authors:  G G Geyskes; P Boer; E J Dorhout Mees
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

8.  Clonidine blocks acute opiate-withdrawal symptoms.

Authors:  M S Gold; D E Redmond; H D Kleber
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

9.  Disposition of clonidine in rats as determined by radioimmunoassay.

Authors:  B Jarrott; S Spector
Journal:  J Pharmacol Exp Ther       Date:  1978-10       Impact factor: 4.030

10.  A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions.

Authors:  S Fielding; J Wilker; M Hynes; M Szewczak; W J Novick; H Lal
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

View more
  10 in total

1.  Opiate receptors and the endorphin-mediated cardiovascular effects of clonidine in rats: evidence for hypertension-induced mu-subtype to delta-subtype changes.

Authors:  R Mosqueda-Garcia; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  WIN 44,441: A Stereospecific and Long-Acting Narcotic Antagonist.

Authors:  P L Wood; C Pilapil; M Thakur; J W Richard
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

3.  Clonidine casualty.

Authors:  M Sanklecha; A Jog; K Raghavan
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

Review 4.  The neuroendocrine response to multiple trauma.

Authors:  D S Gann; M P Lilly
Journal:  World J Surg       Date:  1983-01       Impact factor: 3.352

5.  A comparison of the cardiovascular and sedative actions of the alpha-adrenoceptor agonists, FLA-136 and clonidine, in the rat.

Authors:  T C Hamilton; S D Longman
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

6.  Potentiation by naloxone of pressor reflexes.

Authors:  J L Montastruc; P Montastruc; F Morales-Olivas
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

7.  Alpha-methyldopa induces a naltrexone-insensitive antinociception and hypomotility in rats.

Authors:  P L van Giersbergen; E van Duinkerken; C G Sweep; V M Wiegant; J M van Ree; W de Jong
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

8.  Neuroinflammatory reactions in experimental gastric ulcer: target for mucosal protection.

Authors:  K Gyires
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 4.473

9.  Hypothalamic regulation of the cardiovascular and respiratory systems: role of specific opiate receptors.

Authors:  A I Faden; G Feuerstein
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

10.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.